FundedIQ
Biotechnology

Halo Labs: Funding, Investors & Team (Oct 2026)

Corona Labs (previously Optofluidics) is an endeavor upheld logical instrumentation organization that markets high throughput biopharmaceutical quality control devices utilizing the most recent optics, picture handling, and microfluidics. Its financial backers and improvement accomplices incorporate BioAdvance, the National Science Foundation, the Defense Advanced Research Projects Agency, and the Ben Franklin Technology Partners. In 2012 Optofluidics was named Philadelphia Life Sciences startup of the year. The organization was established in 2011 and settled in Pennsylvania, United States.

halolabs.com LinkedIn Philadelphia, United States 11-50 employees
Analytics Biopharma Biotechnology Health Diagnostics Pharmaceutical
Total raised
$18.0M
Rounds
2
Latest
Series C
Jul 2022

Halo Labs has raised $18.0M across 2 funding rounds on record, the most recent a Series C of $6.0M announced in Jul 2022.

That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Halo Labs Company Profile and Key Stats

Total funding raised
$18.0M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Series C
$6.0M in Jul 2022
Employees
11-50
reported band
Headquarters
Philadelphia, United States

Latest funding round on record: Jul 2022.

Halo Labs Funding Rounds

Date
Round
Amount
Series C
$6.0M
Undisclosed round
$12.0M

Halo Labs raised $12.0M in an undisclosed round announced in Apr 2020.

2.3 years later, a Series C of $6.0M was announced in Jul 2022.

Halo Labs Founders and Leadership Team

Name
Role
Contact
Bernardo Cordovez
CEO
—
Rick Gordon
CEO
Locked

Contact details for the Halo Labs team: 1 of 2 have an email address on file.

Start 14-day free trial →

Halo Labs Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,234
$7.6M
1,869
$60M

Halo Labs' latest round of $6.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Halo Labs in Biotechnology and Philadelphia

Companies Similar to Halo Labs

Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

Halo Labs Funding FAQs

What does Halo Labs do?

Corona Labs (previously Optofluidics) is an endeavor upheld logical instrumentation organization that markets high throughput biopharmaceutical quality control devices utilizing the most recent optics, picture handling, and microfluidics. Its financial backers and improvement accomplices incorporate BioAdvance, the National Science Foundation, the Defense Advanced Research Projects Agency, and the Ben Franklin Technology Partners. In 2012 Optofluidics was named Philadelphia Life Sciences startup of the year. The organization was established in 2011 and settled in Pennsylvania, United States.

How much funding has Halo Labs raised?

Halo Labs has raised $18.0M across 2 rounds on record. The most recent is a Series C of $6.0M announced in Jul 2022.

When did Halo Labs last raise funding?

Halo Labs' most recent funding round on record is a Series C of $6.0M, announced in Jul 2022.

Who is the CEO of Halo Labs?

Bernardo Cordovez is listed as CEO at Halo Labs.

Where is Halo Labs headquartered?

Halo Labs is based in Philadelphia, Pennsylvania, United States.

How many employees does Halo Labs have?

Halo Labs is in the 11-50 employee band.

How does Halo Labs' funding compare to other Biotechnology startups?

Halo Labs' latest round of $6.0M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Halo Labs Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Halo Labs is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.